Literature DB >> 22736073

Anti-proliferative and pro-apoptotic effects of 3,3'-diindolylmethane in human cervical cancer cells.

Junyong Zhu1, Yuan Li, Chao Guan, Zuhua Chen.   

Abstract

The antitumor effects of Indo-3-carbinol (I3C) have been proven in many human carcinoma cells. However, the roles of 3,3-diindolylmethane (DIM), an important polymer converted from I3C under pH 5.0-7.0, on the growth and proliferation of cervical cancer HeLa and SiHa cells still remain unrevealed. In the present study, we investigated the potential anti-proliferative and pro-apoptotic effects of DIM on HeLa and SiHa cells. Cell proliferation was detected by Cell Counting kit-8 and apoptosis was analyzed by flow cytometry. In addition, morphological changes accompanying cell apoptosis were observed using an inverted microscope after Hoechst 33258 staining. In addition, expression changes of proteins involved in the MAPK and PI3K pathways were determined by western blotting. DIM treatment inhibited the proliferation and induced apoptosis of HeLa and SiHa cells significantly in a time- and dose-dependent manner. Moreover, SiHa cells were more sensitive to DIM treatment than HeLa cells (P<0.05). In addition, the expression of ERK, p38 and p-p38, which are involved in the MAPK pathway, was downregulated by DIM treatment. Another protein involved in the MAPK pathway, JNK, was upregulated. Furthermore, DIM treatment significantly suppressed the expression of Akt, p-Akt, PI3K p110α, PI3K p110β, PI3K class III, GSK3-β, p-PDK1 and p-c-Raf which are involved in the PI3K pathway. These results demonstrate that DIM exerts antitumor effects on HeLa and SiHa cells through its anti-proliferative and pro-apoptotic roles, especially for SiHa cells. The molecular mechanism for these effects may be related to its regulatory effects on MAPK and PI3K pathway and apoptosis proteins. DIM may be a preventive and therapeutic agent against cervical cancer.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22736073     DOI: 10.3892/or.2012.1877

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  5 in total

Review 1.  Targeted regulation of PI3K/Akt/mTOR/NF-κB signaling by indole compounds and their derivatives: mechanistic details and biological implications for cancer therapy.

Authors:  Aamir Ahmad; Bernhard Biersack; Yiwei Li; Dejuan Kong; Bin Bao; Rainer Schobert; Subhash B Padhye; Fazlul H Sarkar
Journal:  Anticancer Agents Med Chem       Date:  2013-09       Impact factor: 2.505

2.  3,3'-Diindolylmethane inhibits the invasion and metastasis of nasopharyngeal carcinoma cells in vitro and in vivo by regulation of epithelial mesenchymal transition.

Authors:  Tingting Wu; Chen Chen; Fen Li; Zhe Chen; Yong Xu; Botui Xiao; Zezhang Tao
Journal:  Exp Ther Med       Date:  2014-03-28       Impact factor: 2.447

3.  Double-blind randomized placebo-controlled multicenter clinical trial (phase IIa) on diindolylmethane's efficacy and safety in the treatment of CIN: implications for cervical cancer prevention.

Authors:  Levon Ashrafian; Gennady Sukhikh; Vsevolod Kiselev; Mikhail Paltsev; Vadim Drukh; Igor Kuznetsov; Ekaterina Muyzhnek; Inna Apolikhina; Evgeniya Andrianova
Journal:  EPMA J       Date:  2015-12-21       Impact factor: 6.543

4.  Methanolic extracts from brown seaweeds Dictyota cilliolata and Dictyota menstrualis induce apoptosis in human cervical adenocarcinoma HeLa cells.

Authors:  Dayanne Lopes Gomes; Cinthia Beatrice Silva Telles; Mariana Santana Santos Pereira Costa; Jailma Almeida-Lima; Leandro Silva Costa; Tatjana Souza Lima Keesen; Hugo Alexandre Oliveira Rocha
Journal:  Molecules       Date:  2015-04-13       Impact factor: 4.411

5.  Anti-Cancer Effects of 3, 3'-Diindolylmethane on Human Hepatocellular Carcinoma Cells Is Enhanced by Calcium Ionophore: The Role of Cytosolic Ca2+ and p38 MAPK.

Authors:  Yuanyue Jiang; Yanfei Fang; Yang Ye; Xinming Xu; Bingfang Wang; Jie Gu; Michael Aschner; Jian Chen; Rongzhu Lu
Journal:  Front Pharmacol       Date:  2019-10-09       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.